- Min.Order :1 Kilogram
- Purity: 99.2%
- Payment Terms : T/T
Keywords
Intermediates of Febuxostat High purity 4-HYDROXYTHIOBENZAMIDE 4-hydroxybenzothioamide
Quick Details
- Appearance:White powder
- Application:Intermediates of Febuxostat
- PackAge:Special aluminum foil bag or Cardboard barrels
- ProductionCapacity:10|Metric Ton|Month
- Storage:Stored in shady and cool place, placed in a dry environment, away from moisture and strong light and heat
- Transportation:land carriage
Superiority:
Xinnuo Pharmaceutical Chemical Co., Ltd. Was established in October 2013, the regional office is mainly high and new tech Development Zone, Jinan Jinan trough. Mainly engaged in research, development and production of pharmaceutical and chemical industry of fine chemicals, the company set up under the Weifang Binhai Development Zone test base and Shijiazhuang Economic and Technological Development Zone, Jinzhou production base, is mainly responsible for research and commercial production of products. CIGNA medicine as a pharmaceutical companies in technological innovation, the introduction of the concept of innovative drug research and development, combined with the development situation both at home and abroad, established a set of innovative drug research and development system, for independent intellectual property rights of innovative drugs. At the same time, carbone also focused on the related intermediates research and development and technical services. Company management research and development team by virtue of the depth of understanding and grasp of the drug market, the use of independent new drugs and new technology research and development technology, is about to develop a good market prospects for profitable products.
Details:
Xinnuo Pharmaceutical Chemical Co., Ltd. Was established in October 2013, the regional office is mainly high and new tech Development Zone, Jinan Jinan trough. Mainly engaged in research, development and production of pharmaceutical and chemical industry of fine chemicals, the company set up under the Weifang Binhai Development Zone test base and Shijiazhuang Economic and Technological Development Zone, Jinzhou production base, is mainly responsible for research and commercial production of products. CIGNA medicine as a pharmaceutical companies in technological innovation, the introduction of the concept of innovative drug research and development, combined with the development situation both at home and abroad, established a set of innovative drug research and development system, for independent intellectual property rights of innovative drugs. At the same time, carbone also focused on the related intermediates research and development and technical services. Company management research and development team by virtue of the depth of understanding and grasp of the drug market, the use of independent new drugs and new technology research and development technology, is about to develop a good market prospects for profitable products.
You Might Also Like
-
phthalimide
CAS NO:161596-47-0
-
5-Chlorothiophene-2-carbonyl chloride
CAS NO:42518-98-9
-
4-(4-Aminophenyl)morpholin-3-one
CAS NO:438056-69-0
-
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
CAS NO:641571-11-1
-
Methyl 3-amino-4-methylbenzoate
CAS NO:18595-18-1
-
1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one
CAS NO:55314-16-4
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View